a
Helena Käck, AstraZeneca (Sweden)
aa
Tove Sjögren, AstraZeneca (Sweden)
a
Dave Brown, Vertex (UK)
a
Chun-wa Chung, GSK (UK)
a
Karl Edman, AstraZeneca (Sweden)
aa
Andreas Kuglstatter, Roche (Switzerland)
a
Djordje Musil, Merck Healthcare KGaA (Germany)
a
Linda Öster, AstraZeneca (Sweden)
a
Alexey Rak, Sanofi (France)
aa
Christian Wiesmann, Novartis (Switzerland)
